Oral Pain Relief Gel
Product Images NDC 57896-139

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Oral Pain Relief (NDC 57896-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Geri-care Pharmaceutical Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (139)

This is a drug information leaflet that contains warnings, instructions, and details about inactive ingredients. The drug can cause methemoglobinemia and should be stopped immediately if symptoms such as blue or gray skin, headache, shortness of breath, dizziness, or rapid heart rate occur. Children should not use this drug without adult supervision, and infants should not use this drug at all. It is essential to contact a doctor in case of an overdose or allergic reaction. The drug is sold in the form of a tube, and the tube should not be used if cut before opening. If instructions for use are not clear, the customer can contact the manufacturer.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.